Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UNEX-42
- Development stage
- Unknown
- Lead developer
- United Therapeutics
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
- Administration
- Intratracheal, Intravenous
01
Overview
UNEX-42 (unexisome) is an exosome-based therapeutic candidate consisting of extracellular vesicles (EVs) derived from human bone marrow mesenchymal stem cells (BMSCs). Developed by United Therapeutics, it is currently being investigated in clinical trials for the prevention and treatment of bronchopulmonary dysplasia (BPD) in extremely preterm neonates. The therapy functions by delivering a complex cargo of bioactive molecules, including proteins, lipids, and various RNA species, which exert paracrine effects to modulate inflammatory responses, reduce fibrosis, and promote alveolar and vascular growth in the developing lung. By leveraging the regenerative properties of MSC-derived vesicles without the risks associated with whole-cell transplantation, UNEX-42 aims to mitigate the lung injury caused by mechanical ventilation and oxygen toxicity in high-risk infants.
- Other names
- unexisomebone marrow mesenchymal stem cell-derived extracellular vesiclesBMSC-EVs
Beyond the preview
Go deeper on UNEX-42.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UNEX-42.